Adaptimmune stock plunges after announcing Nasdaq delisting plans
Investing.com - BMO Capital upgraded Primerica (NYSE:PRI) from Market Perform to Outperform on Tuesday, while raising its price target to $318.00 from $292.00. The company, currently trading at a P/E ratio of ~13 with revenue growth of 7.6% in the last twelve months, has demonstrated strong financial performance with a "GREAT" health score according to InvestingPro analysis.
The research firm cited Primerica’s captive salesforce model as a key factor in the upgrade, noting that such distribution structures typically don’t need to compete solely on price.
BMO Capital highlighted that companies with captive or exclusive salesforces—including Primerica, Allstate, Aflac, Globe Life, and more recently CNO—have historically delivered healthy shareholder returns.
The firm specifically pointed to Primerica’s distribution-oriented business model and its focus on middle-income consumers as factors that have supported superior growth, free cash flow conversion, and stock performance compared to peers.
According to BMO Capital, Primerica’s model helps insulate the company from increasing competition at the upper end of the market for certain life and annuity products.
In other recent news, Primerica Inc . reported its financial results for the second quarter of 2025, revealing a significant earnings beat. The company posted a diluted adjusted operating earnings per share (EPS) of $5.46, surpassing analysts’ expectations of $5.20. Revenue also exceeded forecasts, reaching $796.02 million compared to the anticipated $785.84 million. Despite these positive financial results, Primerica’s stock experienced a slight decline. These developments highlight the company’s ability to outperform earnings and revenue projections. This information is crucial for investors monitoring Primerica’s financial health and market performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.